MENLO PARK, Calif., Dec. 9, 2025 /PRNewswire/ ? BillionToOne, Inc. , a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, ...
As of September 30, 2025, BillionToOne held approximately $195.2 million in cash and cash equivalents. The Company raised gross proceeds of $314.0 million from its IPO, which closed on November 7, ...
A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...
Medical Device Network on MSN
Testmate and Intermountain Health partner for STI testing in US
Testmate Health and Intermountain Health have entered a strategic collaboration and investment agreement to expedite the ...
Core to Seegene Mexico are the Allplex and Anyplex HPV 28 Detection assays – real-time multiplexing PCR tests that identify ...
An international team of scientists has unveiled the most comprehensive model yet that explains how cells control the flow of materials in and out of their nuclei—solving one of biology's oldest ...
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury Thermo Fisher Scientific, the world leader in serving science, has introduced a new laboratory ...
Oct 7 (Reuters) - BillionToOne filed for an initial public offering in the United States on Tuesday. The company's filing comes at a time when U.S. IPO activity is picking up, reversing a slowdown ...
FREDERICTON, NB, Sept. 16, 2025 /PRNewswire/ - LuminUltra, a global leader in applied molecular diagnostics, today announced the acquisition of GL Biocontrol, a France-based pioneer in microbial ...
A bottleneck to enabling widespread access to molecular diagnostics, especially in low- and middle-income countries, has been the high cost and complex logistics associated with rapid point-of-care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback